Jump to content

Ciclopirox: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
parser-claude batch MedTemplate pre-fill, Top 300 #278
 
home-claude category backfill (parser-claude gap closure)
 
Line 21: Line 21:
== References ==
== References ==
<references />
<references />
[[Category:Antifungals]]
[[Category:Topical antifungals]]
[[Category:Hydroxypyridones]]

Latest revision as of 10:43, 23 May 2026

Ciclopirox
Penlac (nail lacquer), Loprox (cream/lotion/shampoo)

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Pharmacy
Starting dose
Topical cream/lotion BID; shampoo twice weekly; nail lacquer (Penlac) once daily for up to 48 weeks
Preparations
0.77% topical cream, lotion, suspension; 1% shampoo; 8% nail lacquer (Penlac)
US FDA Max
BID topical; once daily nail lacquer
Pharmacology
Routes
Topical
Onset
Days for dermatophyte clearance; nail clearance over months
Duration
Hours per application
Half-life
Not meaningfully described (topical local action)[1]
Bioavailability
Topical with minimal systemic absorption[1]
Pregnancy
Generally considered safe (minimal systemic absorption).[citation needed]
Legal status
Rx-only in US
Purported mechanism
Ciclopirox is a hydroxypyridone antifungal with a mechanism distinct from azoles and allylamines; it chelates polyvalent cations (Fe³⁺, Al³⁺), disrupting cofactor-dependent fungal enzymes (cytochromes, catalases, peroxidases) and producing fungicidal activity against dermatophytes, Candida, and Malassezia.0 Onychomycosis cure rates with nail lacquer are modest (mycologic cure ~30-50%, complete cure ~5-12% at 48 weeks); oral terbinafine remains substantially more effective when systemic therapy is acceptable[1].

References

  1. 1.0 1.1 1.2 FDA Prescribing Information, Penlac (ciclopirox) topical solution, Sanofi-Aventis, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021022s015lbl.pdf